Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 8.62 % |
3 Month Return | + 2.33 % |
1 Year Return | + 27.91 % |
Market Stats | |
Previous Close | ₹153.81 |
Open | ₹155.65 |
Volume | 1.07L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹549.02Cr |
P/E Ratio | -66.3 |
PEG Ratio | -21.46 |
Market Cap | ₹549.02 Cr |
P/B Ratio | 3.88 |
EPS | -0.79 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹549.02 Cr | 131.91% | 0.69 | -₹3 Cr | ₹111 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Lyka Labs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Lyka Labs Ltd
Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 28.08 Cr → 41.18 Cr (in ₹), with an average increase of 17.0% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, -2.13 Cr → 2.1 Cr (in ₹), with an average increase of 139.7% per quarter
Retail Holding Up
Retail Investor have increased holdings from 40.99% to 41.08% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 165.8%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.15% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 31.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, LYKALABS stock has moved down by -7.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 58.1% | 0.00 | |
Foreign Institutions | 0.15% | 0.00 | |
Mutual Funds | 0.01% | 0.00 | |
Retail Investors | 41.08% | 0.21 | |
Others | 0.66% |
Lyka Labs Ltd in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-66.30x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (23.04x)
September 5, 2022
Lyka Labs Ltd’s net profit jumped 528.57% since last year same period to ₹2.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 45.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Neutral trading position according to technical analysis indicators.
Lyka Labs Ltd (LYKALABS) share price today is ₹149.74
Lyka Labs Ltd is listed on NSE
Lyka Labs Ltd is listed on BSE
PE Ratio of Lyka Labs Ltd is -66.3
PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share
Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 1.07L.
Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹549.02Cr.
Lyka Labs Ltd(LYKALABS | Price |
---|---|
52 Week High | ₹176.59 |
52 Week Low | ₹97.9 |
Lyka Labs Ltd(LYKALABS) share price is ₹149.74. It is down -15.20% from its 52 Week High price of ₹176.59
Lyka Labs Ltd(LYKALABS) share price is ₹149.74. It is up 52.95% from its 52 Week Low price of ₹97.9
Lyka Labs Ltd(LYKALABS | Returns |
---|---|
1 Day Returns | -4.07% |
1 Month Returns | 8.62% |
3 Month Returns | 2.33% |
1 Year Returns | 27.91% |